Collaxio (COLLAX) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
28 Aug, 2025Executive summary
Strategic transformation executed, shifting focus from listed Asian equities to unlisted growth companies via a buy-and-build strategy, including the acquisition of Curitas Ventures AB with 13 unlisted holdings.
Divestment of the previous Asian portfolio and distribution of both ordinary and extraordinary dividends totaling 1.72 SEK per share.
New board and interim CEO appointed to support the new direction; company to operate under the name Collaxio, pending formal name change.
Financial highlights
Net asset value (NAV) at quarter-end was SEK 88m (3.02 SEK/share), down from SEK 113m (3.88 SEK/share) at the start of the quarter.
Total comprehensive income for Q2 was -SEK 15m (-14m YoY); for H1, -SEK 22m (-8m YoY).
Extraordinary dividend of 1.52 SEK/share (SEK 44m) in addition to the regular dividend of 0.20 SEK/share.
Cash and cash equivalents at quarter-end were SEK 82.8m, up from SEK 4.0m YoY, mainly due to asset sales.
Outlook and guidance
Effects of the Curitas Ventures acquisition will be reflected in Q3; post-transaction NAV estimated at SEK 109m (1.79 SEK/B-share).
Management sees opportunities for further portfolio acquisitions and value creation in the unlisted segment.
Latest events from Collaxio
- Strategic shift to unlisted assets and acquisitions drove transformation, but NAV per share fell.COLLAX
Q4 202520 Feb 2026 - Strategisk omställning och portföljförvärv ledde till minskat substansvärde och negativt resultat.COLLAX
Q3 20257 Nov 2025 - NAV per share up 11% in Q3, with strong portfolio growth and improved profitability.COLLAX
Q3 202413 Jun 2025 - Substansvärdet per stamaktie minskade 11% under H1 2024, men resultatet förbättrades.COLLAX
Q2 202413 Jun 2025 - Substansvärdet minskade 6% och hela portföljen föreslås avyttras med extrautdelning.COLLAX
Q1 20256 Jun 2025 - Stark vändning till positivt resultat och höjd utdelning trots lägre substansvärde.COLLAX
Q4 20245 Jun 2025